Skip to main content

Table 3 Outcome parameters

From: Outcomes and complication rates of different bone grafting modalities in long bone fracture nonunions: a retrospective cohort study in 182 patients

Variable

Autograft

Allograft

Autograft/allograft

rhBMP-2

n

105

38

16

23

Time to union in days (mean ± 95% CI)

198* (172–225)

416 (290–543)

389 (159–619)

217 (158–277)

Surgical revision rate (any unplanned return to the OR)

18** (17.1%)

18 (47.4%)

4 (25.0%)

6 (26.1%)

Revision bone grafting/nonunion rate

9** (8.6%)

12 (31.6%)

5 (31.3%)

4 (17.4%)

New-onset postoperative infection

13*** (12.4%)

10 (26.3%)

1 (6.3%)

4 (17.4%)

Superficial

5 (4.8%)

1 (2.6%)

0 (0%)

0 (0%)

Deep

8 (7.6%)

9 (23.7%)

1 (6.3%)

4 (17.4%)

Persisting infection

3 (2.9%)

3 (7.9%)

1 (6.3%)

1 (4.3%)

  1. rhBMP-2 recombinant human bone morphogenetic protein-2.
  2. Data in the time to union row are expressed as mean ± 95% CI.
  3. * (P < 0.001), statistically significant between autograft and allograft cohorts.
  4. ** (P < 0.01), statistically significant between autograft and all other cohorts.
  5. *** (P < 0.05), statistically significant between autograft and allograft groups.